ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Spondylarthropathy"

  • Abstract Number: 560 • 2019 ACR/ARP Annual Meeting

    Dactylitis Occurrence in Early Spondyloarthritis: Five Years Data from a French National Prospective Cohort

    Daniel WENDLING1, Clément PRATI 2, Alain Saraux 3, Anna Moltó 4, Thao PHAM 5, Maxime Dougados 6 and Xavier GUILLOT 7, 1Rheumatology, University Teaching Hospital (CHRU), Besançon, France, 2University Teaching Hospital (CHRU), Besançon, France, 3CHU de la Cavale-Blanche Brest, Brest, France, 4Paris Descartes University, Cochin Hospital, Rheumatology department, Paris, France, 5CHU, Marseille, France, 6Cochin Hospital, Paris, France, 7CHU, Saint Denis de la Réunion, Reunion

    Background/Purpose: Dactylitis is a particular feature shared across the several phenotypical forms of spondyloarthritis (SpA), part of the classification criteria. There are only few data…
  • Abstract Number: 589 • 2019 ACR/ARP Annual Meeting

    Smoking, Alcohol Intake and Body Mass Index in Prediction of Disease Activity over Time in Early Axial Spondyloarthritis – Results from the SPondyloArthritis Caught Early (SPACE) Cohort

    Sofia Exarchou 1, Carl Turesson1, Ulf Lindström 2, Roberta Ramonda 3, Robert B.M. Landewé 4, Hanne Dagfinrud 5, Floris van Gaalen 6, Désirée van der Heijde 6 and Lennart Jacobsson 7, 1Lund University, Malmö, Sweden, 2University of Gothenburg, Gothenburg, Sweden, 3University of Padova, Padova, Italy, 4Amsterdam University Medical Center, Amsterdam, Netherlands, 5University of Oslo, Oslo, Norway, 6Leiden University Medical Center, Leiden, Netherlands, 7Dept of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden,, Gothenburg, Sweden

    Background/Purpose: In ankylosing spondylitis (AS), smokers have been found to have both higher disease activity and greater syndesmophyte progression, and a higher body mass index…
  • Abstract Number: 1247 • 2019 ACR/ARP Annual Meeting

    Adult-Onset Still’s Disease and Spondyloarthritis: Overlapping Syndrome or Incidental Association? A Series of 5 Cases

    Aly Kamissoko 1, Nolan Hassold 2, Alexis Mathian 3, Edouard Pertuiset 4, Gaetane Nocturne 2, Bruno Fautrel 5 and Stéphane Mitrovic6, 1AP-HP, Department of Rheumatology, Pitié-Salpêtrière University Hospital, Paris, France, Paris, France, 2Center for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, Université Paris Sud, INSERM, Paris, France., Paris, France, 3AP-HP, Service de Médecine Interne 2, Hôpital Universitaire Pitié-Salpêtrière, Paris, France, Paris, France, 4Rheumatology Department, Pontoise Hospital, Pontoise, France, Pontoise, France, 5Pitié-Salpêtrière Hospital, Department of Rheumatology, AP-HP, Sorbonne University, UPMC university, Paris, Ile-de-France, France, 6AP-HP, Department of Rheumatology, Pitié-Salpêtrière University Hospital, Sorbonne Université, GRC 08, Pierre Louis Institute of Epidemiology and Public Health, Paris, France - Centre d’Etude et de Référence sur les Maladies AutoInflammatoires et les Amyloses (CEREMAIA), FAI2R network, Paris, France - Institut Mutualiste Montsouris, Paris, France, Paris, France

    Background/Purpose: Some forms of spondyloarthritis (SpA) such as SAPHO syndrome are classified as auto-inflammatory disorders. Association with adult onset Still’s disease (AoSD) has never been…
  • Abstract Number: 2092 • 2019 ACR/ARP Annual Meeting

    Efficacy and Safety of the Adjuvanted Recombinant Zoster Vaccine in Adults with Pre-existing Potential Immune Mediated Diseases: A Pooled Post-hoc Analysis on Two Parallel Randomized Trials

    Alemnew Dagnew1, Debora Rausch 2, Caroline Hervé 3, Toufik Zahaf 4 and Anne Schuind 1, 1GSK, Rockville, MD, 2GSK, Philadelphia, PA, 3GSK, Wavre, Belgium, 4GSK, Rixensart, Belgium

    Background/Purpose: The increased risk of herpes zoster (HZ) in older adults is attributable to age-related decline in immunity. In 2 pivotal studies, ZOE-50 (NCT01165177) and…
  • Abstract Number: 2716 • 2016 ACR/ARHP Annual Meeting

    Does Secretory Immunoglobulin a Influence Disease Activity in Patients with Reactive Arthritis and Undifferentiated Spondylarthritis?

    fabian Alexander salas-Cuestas1, Consuelo Romero Sanchez2,3, WILSON BAUTISTA-MOLANO4, Juan Manuel Bello-Gualtero5,6, Ivonne Arias C7, Daniel Herrera8 and Rafael Valle-Oñate6,9, 1School of Medicine, Universidad Militar Nueva Granada, Bogotá, Colombia, Bogota DC, Colombia, 2Rheumatology, School of Medicine HMC / UMNG, Bogota, Colombia, 3Rheumatology and Immunology, Hospital Militar Central, Bogota DC, Colombia, 4Rheumatology Department, School of Medicine, UMNG / HMC, Bogotá, Colombia, 5Faculty of Medicine, Universidad Militar Nueva Granada, Bogotá, Colombia, 6Rheumatology and Immunology Department,Hospital Militar Central, Bogota, Colombia, 73. Instituto de Genética Humana, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia., Bogota DC, Colombia, 8Genetic, Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia, 9School of Medicine, Universidad Militar Nueva Granada, Bogota, Colombia

    Background/Purpose: Spondylarthropathies (SpA) comprise a group of rheumatic diseases such as ankylosing spondylitis (AS), arthritis/spondylitis with inflammatory bowel disease, arthritis/spondylitis with psoriasis (PsA), reactive arthritis…
  • Abstract Number: 2492 • 2012 ACR/ARHP Annual Meeting

    Protective and Pathogenic Effects of the IL-23 Family of Cytokines in Spondyloarthropathy in SKG Mice

    Helen Benham1, Linda Rehaume1, Merja Ruutu1, Jared Velasco1, Kristine Kikly2, Geoffrey Strutton3, Michael McGuckin4 and Ranjeny Thomas1, 1Diamantina Institute, Diamantina Institute University of Queensland, Brisbane, Australia, 2Biotechnology Discovery Research, Eli Lilly and Co., Indianapolis, 3Dept of Pathology, Department of Pathology, Princess Alexandra Hospital, Brisbane, Australia, 4Mater Medical Research Institute, Brisbane, Australia

    Background/Purpose: , IL-23 is required for the expansion and maintenance of T cells and innate cells secreting IL-17 and IL-22. These cytokines are important for…
  • Abstract Number: 2493 • 2012 ACR/ARHP Annual Meeting

    The Presence of HLA-B27 Shapes Gut Microbiome Composition in Rats

    Mary H. Bach1, Russell N. Van Gelder2, Joel D. Taurog3 and James T. Rosenbaum4, 1Rheumatology, University of Washington Medical Center, Seattle, WA, 2Ophthalmology, University of Washington Medical Center, Seattle, WA, 3Internal Medicine, Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, 4Arthritis and Rheumatic diseases, Oregon Health and Science University, Portland, OR

    Background/Purpose: The association of spondyloarthropathies (SpA) with HLA-B27 was first described in 1973. However, the mechanism remains unknown. The HLA-B27-human beta2 microglobulin (B27/hβ2m) transgenic (TG)…
  • Abstract Number: 2494 • 2012 ACR/ARHP Annual Meeting

    Incidence and Severity of Spondyloarthritis and Crohn’s Ileitis Are Determined by Interaction Between the Microbiota and Genetic Susceptibility in Beta-Glucan-Treated SKG Mice

    Ranjeny Thomas1, Linda Rehaume1, Daniel Aguirre de Cárcer2, Stan Mondot2, Jared Velasco1, Helen Benham1, Merja Ruutu1, Mark Morrison2 and Michael McGuckin3, 1University of Queensland Diamantina Institute, Brisbane, Australia, 2CSIRO Livestock Industries, Brisbane, Australia, 3Mater Medical Research Institute, Brisbane, Australia

    Background/Purpose: Spondyloarthritis and inflammatory bowel disease (IBD) or microscopic gut inflammation co-exist in many patients. These conditions share genetic associations in the IL23R signaling pathway.…
  • Abstract Number: 2409 • 2012 ACR/ARHP Annual Meeting

    Work Productivity in a Population Based Cohort of Patients with Spondyloarthritis

    Emma Haglund1, Ann B. I. Bremander2, Stefan Bergman1, Lennart TH Jacobsson3, Britta Strömbeck4 and Ingemar F. Petersson4, 1Spenshult Hospital, R&D Center Spenshult, Oskarstrom, Sweden, 2Department of Exercise Physiology, Biomechanics and Health, Halmstad University School of Business and Engineering,, Halmstad, Sweden, 3Rheumatology/Lund University, Department of Rheumatology, Clinical sciences, Skane University Hospital, Malmö, Sweden, 4Musculoskeletal Sciences, Department of Orthopedics, Clinical Sciences, Lund, Sweden

    Background/Purpose: Spondyloarthritis (SpA) often causes impaired function, activity limitations, affected health related quality of life and work disability. Work disability has been shown to be…
  • Abstract Number: 2232 • 2012 ACR/ARHP Annual Meeting

    Performance of Berlin Criteria in Patients with EARLY Spondyloarthritis

    Beatriz E. Joven1, Milena Gobbo2, Miguel A. Descalzo3, Eugenio De Miguel4 and Esperanza Group5, 1Rheumatology, HOSPITAL UNIVERSITARIO 12 DE OCTUBRE, Madrid, Spain, 2Research Unit, Spanish Society of Rheumatology., Madrid, Spain, 3Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 4Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 5Madrid

    Background/Purpose: Berlin criteria are a diagnostic algorithm based on calculation of the likelihood ratio (LR) product of currently available diagnostic test for spondyloarthritis (SpA).  However,…
  • Abstract Number: 1701 • 2012 ACR/ARHP Annual Meeting

    Validation of the New ASAS Criteria for Classification of Early Spondyloarthritis in the Esperanza Cohort

    Eva Tomero1, Loreto Carmona2, Juan Mulero3, Eugenio De Miguel4, Milena Gobbo5, Carmen Martínez6, Miguel A. Descalzo6, Pedro Zarco7, Eduardo Collantes-Estevez8 and Esperanza Group9, 1Rheumatology, Hospital Universitario de La Princesa. IIS La Princesa, Madrid, Spain, 2Health Sciences School, Universidad Camilo José Cela, Villanueva de la Cañada, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, 4Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 5Research Unit, Spanish Society of Rheumatology., Madrid, Spain, 6Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 7Unit Rheumatology, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 8Depatamento de Medicina, IMIBIC-Reina Sofia Hospital, Cordoba 14012, Spain, 9Madrid

    Background/Purpose: To validate the new axial and peripheral ASAS criteria in patients with early spondyloarthritis (SpA) and the full spectrum of clinical manifestations under clinical…
  • Abstract Number: 1378 • 2012 ACR/ARHP Annual Meeting

    Validity of Ankylosing Spondylitis Disease Activity Score (ASDAS) in Patients with Early Spondyloarthritis

    Cruz Fernández-Espartero1, Eugenio De Miguel2, Milena Gobbo3, Carmen Martínez4, Miguel A. Descalzo4, Estíbaliz Loza Sr.5 and Esperanza Group6, 1Servicio de Reumatología, Hospital Universitario de Móstoles, Madrid, Spain, 2Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 3Research Unit, Spanish Society of Rheumatology., Madrid, Spain, 4Research Unit, Spanish Society of Rheumatology, Madrid, Spain, 5Research Unit. Sociedad Española de Reumatología, Madrid, Spain, 6Madrid

    Background/Purpose: Recently, a Working Group of the SpondyloArtrhitis International Society (ASAS) has proposed a composite disease activity score, the Ankylosing Spondylitis Disease Activity Score (ASDAS),…
  • Abstract Number: 1362 • 2012 ACR/ARHP Annual Meeting

    Evaluation of Spondyloarthritis activity  by the Patients and the Physicians: ASDAS, Basdai, PASS and Flare

    Marie Godfrin-Valnet1, Clément Prati2, Marc Puyraveau3, Eric Toussirot4, Helene Letho-Gyselinck5 and Daniel Wendling5, 1Rheumatology, CHU, Besançon, France, 2Service de Rhumatologie, CHU J Minjoz, Besancon, France, 3Clinical Methodology Center, CHU, Besançon, France, 4Université de Franche Comté , CHRU, CIC Biotherapy 506 and Rheumatology and EA 4266 Pathogens and Inflammation, Besançon, France, 5Service de Rhumatologie, Minjoz University Hospital, Besancon, France

    Background/Purpose: Objectives: to define thresholds of the ASDAS corresponding to the PASS (Pateint Acceptable Symptomatic State) and to the thresholds of activity of the disease…
  • Abstract Number: 1343 • 2012 ACR/ARHP Annual Meeting

    EARLY Improvements in the Lower Limbs Enthesis by Ultrasound Predicting Later Favorable Responses in TNF Inhibotors-Treated Patients with Spondyloarthritis

    Kensuke Kume1, Kanzo Amano1, Kuniki Amano2, Hiroyuki Ohta3 and Noriko Kuwaba4, 1Rheumatology, Hiroshima Clinic, Hiroshima, Japan, 2Rheumatology, Sky Clinic, Hiroshima, Japan, 3Medical Research, hiroshima clinic, Hiroshima, Japan, 4Medical Research, Sanki Clinical Link, Hiroshima, Japan

    Background/Purpose: Lower limbs enthesis by ultrasound (US) detects inflammatory activity in patients with spondyloarthritis(SpA) and is a diagnostic tool of early SpA. The present objective…
  • Abstract Number: 593 • 2012 ACR/ARHP Annual Meeting

    DKK1 Serum Level Is Increased in Recent Spondyloarthritis and Is Associated with Higher Prevalence of Syndesmophytes. Sclerostin Is Highly Correlated with Age. Data From the DESIR Cohort

    Gaetane Nocturne1, Stephan Pavy2, Désirée van der Heijde3, Philipe M. Goupille4, Maxime Dougados5, Christian Roux6, Xavier Mariette7 and Corinne Miceli-Richard2, 1INSERM U1012, Université Paris Sud, Le Kremlin Bicêtre, France, 2Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 3Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Hopital Trousseau, Tours, France, 5Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, 6Paris Descartes University, Paris, France, 7Rheumatology, Université Paris-Sud, Le Kremlin Bicetre, France

    Background/Purpose: Dickkopf-1 (DKK-1) and sclerostin (SOST) are 2 inhibitory proteins of the Wnt signalling pathway that could rationally be involved either in AS osteoporosis or…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology